Cybin announces two new drug candidates for its R&D pipeline as its pre-clinical research deepens.
Cybin announces two new drug candidates for its R&D pipeline as its pre-clinical research deepens.
Field Trip closes on a CAD$95 million bought deal financing, nearly double the original CAD$50 million offering.
Red Light Holland imports psilocybin truffles into Canada from its Netherlands supply source.
Numinus announces a CAD$30 million bought deal financing with units priced at CAD$1.25.
MINDCURE's new COO, Tarik Lebbadi, recently led an international division of Johnson & Johnson.
Numinus expands its research lab, including more research space, supply capacity and accelerated IP development.
Compass expecting to report data from its Phase IIb study by the end of 2021. Cash on hand decreases to $190.3 million, from $196.5 million the previous quarter.
Adelia Therapeutics, a subsidiary of Cybin Corp., achieves API synthesis and optimization on trypatmine derivatives.
Red Light Holland gets its VR "experience" hosted on the largest PC gaming platform.
This approval is a key step forward in the development of the company's iSTRYM digital therapeutics platform
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now